Is the periodic repetition of a coagulation check necessary during anti-hepatitis C virus therapy? (Record no. 16298750)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01199 a2200349 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515025250.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200606s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0017-5749 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1136/gut.2006.091496 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Capra, F |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20060606 |
245 00 - TITLE STATEMENT | |
Title | Is the periodic repetition of a coagulation check necessary during anti-hepatitis C virus therapy? |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Gut |
Date of publication, distribution, etc. | Jun 2006 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 902 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Case Reports; Letter |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Blood Coagulation Disorders |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Blood Coagulation Tests |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Factor VIII |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hepatitis C, Chronic |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Interferon alpha-2 |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Interferon-alpha |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Polyethylene Glycols |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Recombinant Proteins |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nicolini, N |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Franchini, M |
773 0# - HOST ITEM ENTRY | |
Title | Gut |
Related parts | vol. 55 |
-- | no. 6 |
-- | p. 902 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1136/gut.2006.091496">https://doi.org/10.1136/gut.2006.091496</a> |
Public note | Available from publisher's website |
No items available.